Not available
Quote | Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Last: | $204.65 |
---|---|
Change Percent: | 0.14% |
Open: | $218.08 |
Close: | $204.65 |
High: | $220 |
Low: | $204.16 |
Volume: | 575,050 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
News | Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison. We offer our deepest condolences to Stephen’s family for their loss. Stephen was a colleague and friend to so many of us at Madrigal. H...
2024-04-24 13:02:30 ET Summary Madrigal Pharmaceuticals, Inc. recently received FDA approval for its lead candidate resmetirom, targeting a liver condition called NASH. The NASH market is projected to reach $50 billion by 2035, making it a significant opportunity for Madrigal Phar...
Message Board Posts | Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $MDGL News Article - Madrigal Receives Breakthrough Therapy Designation from FDA for Re | whytestocks | investorshangout | 04/18/2023 2:45:47 PM |
whytestocks: $MDGL News Article - Madrigal Pharmaceuticals Provides Corporate Updates and Reports 20 | whytestocks | investorshangout | 02/23/2023 8:40:52 PM |
$MDGL: $HEPA is the Cheapest value in NASH space | makinezmoney | investorshub | 12/30/2022 4:19:12 PM |
$500 will be here soon enough! | TechandBio | investorshub | 12/30/2022 1:38:11 AM |
Riding free shares 300% profits last week was | TechandBio | investorshub | 12/26/2022 2:54:17 AM |
News, Short Squeeze, Breakout and More Instantly...
Madrigal Pharmaceuticals Inc. Company Name:
MDGL Stock Symbol:
NASDAQ Market:
Madrigal Pharmaceuticals Inc. Website:
CONSHOHOCKEN, Pa., April 24, 2024 (GLOBE NEWSWIRE) -- The Madrigal team is shocked and saddened to learn of the passing of Dr. Stephen Harrison. We offer our deepest condolences to Stephen’s family for their loss. Stephen was a colleague and friend to so many of us at Madrigal. H...
CONSHOHOCKEN, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that it will release its first-quarter 2024 financial results on Tuesday, May 7, 2024, prior to the open of the U.S. financial markets. Following the announcement, Mad...
2024-04-23 06:30:13 ET Bank of America Securities analyst issues UNDERPERFORM recommendation for MDGL on April 22, 2024 06:15AM ET. MDGL was trading at $213.49 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations ar...